Moreover, the product will be available to patients at Accredo, which is the PBM’s specialty pharmacy. What CVS Caremark is ...

Cigna reported a $300 million first quarter loss as the company grapples with the loss in value of its investment in ...

Evernorth Health Services' initiative to offer Humira biosimilar with $0 out-of-pocket costs for patients. Save an average of ...

Evernorth's Accredo arm will make a Humira biosimilar available to patients with no out-of-pocket costs, the company ...

Tricare beneficiaries may now receive specialty drugs at lower copays through Tricare Home Delivery, according to the ...

CVS is getting into the business of making copycat biologic drugs, known as biosimilars, to profit directly from blockbusters ...

Cigna plans to make close copies of AbbVie's blockbuster arthritis drug Humira available with no out-of-pocket payment to ...

Operator instructions] As a reminder, ladies and gentlemen, this conference, including the Q&A session, is being recorded. We ...

In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health Services announced that it will have a Humira® biosimilar ...

Evernorth Health Services will offer Humira biosimilar products with no out-of-pocket cost through its Accredo specialty ...

For many employers, unions, municipalities and other health plan sponsors that choose to work with Accredo as part of their specialty pharmacy network offering, this represents an opportunity for ...

Ladies and gentlemen, thank you for standing by for The Cigna Group's First Quarter 2024 Results Review. (Operator Instructions) As a reminder, ladies and gentlemen, this conference, including the Q&A ...